Venous thromboembolic disease in patients with small cell lung cancer: incidence and clinicopathological risk factors Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020
Silent venous thromboembolism (VTE) in patients undergoing thoracic surgery in the course of lung cancer. Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Effect of statin therapy in patients with lung cancer on mortality, incidence of infections and pulmonary embolism Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Frequency of thromboembolic events in patients with lung cancer at the time of diagnosis and in the course of disease Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011
Different mortality, recurrence and bleeding between cancer and non cancer patients with pulmonary embolism (PE): 1 year follow-up. Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017
The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012
Venous thromboembolic disease and bronchial cancer Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012
Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients. Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018
Venous thromboembolism in lung cancer with clinical analysis of 89 cases Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012
Risk of venous thromboembolism in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 73s Year: 2004
Venous thromboembolic (VTE) in patients with ALS: an incidence study Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021
Five cases of breast cancer complicated with pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 45s Year: 2006
Recurrence and bleeding in the extended treatment of patients with pulmonary embolism (PE) and cancer Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism Year: 2018
A bleeding problem in lung cancer patients Source: Eur Respir J 2015; 45: 601-603 Year: 2015
COPD and risk of venous thromboembolism and mortality in a general population Source: Eur Respir J 2016; 47: 473-481 Year: 2016
The incidence of chronic thromboembolic pulmonary hypertension (CTEPH): a 25-year population-based study Source: Eur Respir J 2003; 22: Suppl. 45, 462s Year: 2003
Does d-dimer level predict pulmonary thromboembolism diagnosis in patients with lung cancer? Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Risk quantification for postoperative pulmonary complications after pulmonary resection in lung cancer patients Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients Year: 2008
Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018
Perioperative pulmonary complications and management of patients with COPD and esophageal malignancy Source: Annual Congress 2011 - COPD management Year: 2011